Mafalda Oliveira Selected Research

Mafalda Oliveira Research Topics

Disease

47	Breast Neoplasms (Breast Cancer) 03/2024 - 06/2011
28	Neoplasms (Cancer) 03/2024 - 11/2015
11	Disease Progression 11/2023 - 10/2017
9	Triple Negative Breast Neoplasms 03/2024 - 10/2017
7	Diarrhea 06/2023 - 11/2019
7	Brain Neoplasms (Brain Tumor) 01/2023 - 06/2011
4	Neutropenia 02/2022 - 10/2017
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 01/2022
3	COVID-19 11/2022 - 12/2021
2	Exanthema (Rash) 06/2023 - 01/2020
2	Hypertension (High Blood Pressure) 01/2023 - 02/2022
2	Pathologic Complete Response 03/2022 - 03/2022
2	Dyspnea (Shortness of Breath) 12/2021 - 12/2021
2	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2021
2	Fatigue 07/2021 - 01/2020
2	Febrile Neutropenia 01/2021 - 01/2020
2	Hyperglycemia 01/2020 - 11/2019
2	Central Nervous System Diseases (CNS Diseases) 01/2020 - 01/2020
2	Meningeal Carcinomatosis 11/2015 - 06/2011
1	Pressure Ulcer (Bedsore) 01/2023
1	Critical Illness (Critically Ill) 11/2022
1	Deglutition Disorders (Dysphagia) 09/2022
1	Dysarthria (Spastic Dysarthria) 09/2022
1	Pneumonia (Pneumonitis) 09/2022
1	Paresis (Hemiparesis) 09/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Synkinesis 01/2022
1	Constipation 07/2021
1	Anemia 01/2021

Drug/Important Bio-Agent (IBA)

16	Hormones (Hormone)IBA 11/2023 - 10/2016
15	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2015
9	Capecitabine (Xeloda)FDA Link 01/2023 - 06/2011
9	Trastuzumab (Herceptin)FDA Link 01/2023 - 06/2011
8	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 10/2017
7	Phenobarbital (Luminal)FDA Link 03/2024 - 01/2017
7	ipatasertibIBA 12/2023 - 01/2017
7	Lapatinib (GW572016)FDA Link 11/2021 - 06/2011
6	Estrogen ReceptorsIBA 01/2023 - 11/2019
5	human ERBB2 proteinIBA 02/2024 - 10/2016
5	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 01/2020
5	ErbB Receptors (EGF Receptor)IBA 01/2024 - 12/2020
5	Fulvestrant (Faslodex)FDA Link 11/2023 - 01/2018
4	ribociclibIBA 03/2024 - 01/2020
4	Letrozole (Femara)FDA LinkGeneric 03/2024 - 06/2011
4	taxaneIBA 12/2023 - 11/2019
4	Circulating Tumor DNAIBA 01/2023 - 11/2019
4	AnthracyclinesIBA 01/2023 - 06/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2019
4	neratinibIBA 11/2021 - 01/2020
4	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 11/2019 - 01/2018
3	RNA (Ribonucleic Acid)IBA 03/2024 - 11/2021
3	capivasertibIBA 06/2023 - 01/2020
3	tucatinibIBA 01/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 03/2022 - 11/2021
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2016
3	eribulin FDA Link 11/2021 - 01/2021
2	Surface Antigens (Surface Antigen)IBA 02/2024 - 01/2021
2	Cyclin-Dependent Kinase 4IBA 01/2024 - 06/2023
2	atezolizumabIBA 12/2023 - 08/2020
2	Immune Checkpoint InhibitorsIBA 12/2023 - 08/2020
2	Aromatase InhibitorsIBA 11/2023 - 06/2023
2	sacituzumab govitecanIBA 01/2023 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 02/2007
2	palbociclibIBA 12/2020 - 11/2020
2	Protein Isoforms (Isoforms)IBA 10/2020 - 11/2019
2	Loperamide (Imodium)FDA LinkGeneric 01/2020 - 01/2020
2	pertuzumabIBA 01/2020 - 01/2019
2	AntibodiesIBA 01/2020 - 01/2020
2	Tamoxifen FDA LinkGeneric 11/2019 - 06/2011
1	Histones (Histone)IBA 03/2024
1	ChromatinIBA 03/2024
1	HeterochromatinIBA 03/2024
1	130-nm albumin-bound paclitaxelIBA 12/2023
1	molibresibIBA 11/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	AlbuminsIBA 01/2023
1	Estrogens (Estrogen)FDA Link 12/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 03/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 03/2022
1	Type A Botulinum Toxins (Botox)FDA Link 01/2022
1	AlpelisibIBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	PlatinumIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	patritumab deruxtecanIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021

Therapy/Procedure

29	Therapeutics 12/2023 - 01/2017
11	Drug Therapy (Chemotherapy) 03/2024 - 06/2011
5	Neoadjuvant Therapy 01/2023 - 01/2019
4	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2022
2	Mechanical Ventilators (Ventilator) 12/2021 - 12/2021
2	Cardiac Rehabilitation 12/2021 - 12/2021
1	Aftercare (After-Treatment) 06/2023
1	Length of Stay 11/2022